Objectives This study aimed to analyze whether blood pressure (BP) measurement is concordant between ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM), and determine whether the decision on treatment changes is similar on the basis of information provided by both methods.
Introduction
Hypertension (HTN) is a powerful risk factor responsible for significant cardiovascular morbidity and mortality worldwide [1] . Effective antihypertensive treatment prevents the occurrence of cardiovascular events irrespective of the antihypertensive agent used [2] . Traditionally, the diagnosis of HTN has been made with office blood pressure (BP) measurements, but BP assessment in an environment away from the office, using ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM), has gained acceptance [3, 4] . The development of automated oscillometric devices validated by international guidelines and consensus has led to widespread use of both methods [1, 5] . ABPM and HBPM provide multiple measurements reflecting BP variations that enable a more precise diagnosis of HTN and assessment of its proper control during day and night compared with office monitoring [6] [7] [8] . Both methods enable the diagnosis of white-coat and masked HTN, and have proven to be more effective than office measurements in the prediction of cardiovascular events, target organ damage, and prognosis [9] [10] [11] . The main advantage of ABPM over HBPM is the capability to follow BP behavior during sleep [12, 13] .
The extent by which additional information provided by ABPM impacts on therapeutic decisions compared with the information provided by HBPM has not been clarified. The objectives of this study were as follows:
(1) Compare systolic blood pressure (SBP) and diastolic blood pressure (DBP) averages measured by both techniques. (2) Evaluate concordance between ABPM and HBPM to determine whether HTN is controlled. (3) Determine whether the decision to make changes in the treatment of patients with HTN is similar on the basis of the information provided by both methods. (4) Assess whether an algorithm that combines both methods in complementary manner is beneficial in treated hypertensive patients.
Methods
Patients of 18 years or older with the diagnosis of HTN who were treated at our institution and required ABPM to evaluate therapeutic efficacy and/or diagnose resistant HTN were invited to participate in the study. [16] . These measurements were performed before the administration of antihypertensive medication. All values were registered and compared with those recorded in the device memory. This protocol was in agreement with the European and American Hypertension guidelines that recommend HBPM for at least 3 days, preferably 7 days, with a minimum of two samples in the morning and two at night [1, 16, 17] . During the first day, HBPM was performed in the dominant arm and when ABPM was concluded, HBPM readings were switched to the nondominant arm. The average BP was calculated for both monitoring methods and cut-off limits to define uncontrolled HTN were established according to recommendations of the European Society of Hypertension (Table 1 ) [1, 18] .
Criteria that had to be fulfilled to modify treatment were also pre-established. For ABPM change of medication, criteria were that average BP during 24 h, daytime, or night-time period exceeded the normal limits or demonstration of abnormal sleeping patterns such as nondipper (nocturnal/diurnal BP relationship > 0.9) or over-dipper (nocturnal/diurnal BP relationship < 0.8) [1, 19, 20] . For HBPM information, change of medication criterion was that average SBP or DBP exceeded normal values established by guidelines (Table 1 ) [1, 18] . Finally, to assess the advantages of using both outpatientmonitoring methods in a complementary manner, we applied an algorithm described by Pickering et al. [21] . This protocol was originally conceived for patients with no history of HTN; thus, this is the first report in treated hypertensive patients. The algorithm started evaluation of all hypertensive patients using HBPM. Those with BP less than 125/75 mmHg would continue with the same treatment; those with BP more than 135/85 mmHg should have their medication adjusted; and patients with BP between 125/75 and 135/85 mmHg should be evaluated with ABPM to confirm whether HTN is properly controlled.
Statistical analysis
For continuous variables, data were expressed as mean ( ) SD or median ( ) range; differences compared using the Student t-test or the Mann-Whitney test when appropriate. For discrete variables, data were expressed as percentages and were compared using the χ 2 -test or the Fisher test when appropriate.
To evaluate concordance index of SBP and DBP between both methods, an interclass correlation coefficient was calculated according to the Bland-Altman method [22] .
The concordance between both methods to determine the adequate BP control was determined by the calculation of the κ index using the scale proposed by Altman Finally, the absolute frequencies (%) for change of treatment were calculated for both BP monitoring modalities and compared using McNemar's method.
Results

Patient characteristics
Between September 2012 and July 2013, 200 treated hypertensive patients were included. The baseline characteristics are summarized in Table 2 . There were 116 men and 84 women, with an average age of 56 12 years. Overall, 38% were dyslipemic, 19% were diabetic, 15% were smokers, 8% had known coronary artery disease, and 9% had suffered previous cardiovascular events. In all, 40% of patients were receiving antihypertensive treatment with one drug, 38% with two drugs, and 22% with three or more drugs.
Similarity between both methods in the measurement of systolic and diastolic blood pressures ABPM diurnal SBP average was 136 16 and 136 15 mmHg (P = 1) by HBPM; DBP was 83 12 and 81 9 mmHg, respectively (P = 0.06) ( Table 3 (Fig. 6 ).
Discussion
This study shows that both ambulatory monitoring methods are concordant in SBP and DBP measurements. Both methods also agree if BP is properly controlled in hypertensive-treated patients. Changes in HTN treatment on the basis of information provided by both methods were significantly higher with ABPM because of sleep time BP behavior monitoring.
The 2013 Hypertension European Guidelines recommend HBPM as a first-line strategy in HTN management because of simplicity, wide availability, low cost, and patient convenience [1] . Day-to-day BP variability can be assessed using this method for extended periods, enabling long-term HTN evaluation [7, 23] . ABPM can also provide detailed information on the daily activity influence on BP, but its major advantage over HBPM is that it provides sleep hour measurements allowing nocturnal HTN diagnosis, and relative changes to average day BP, such as dipping, nondipping, and over-dipping patterns of nocturnal BP. The main limitations of ABPM are the high cost for its widespread use and the moderate discomfort that some patients experience [24] . Considering the advantages and disadvantages of both methods, they should be considered complementary rather than competitive or alternative [1] .
In this study, we aimed to verify whether their results are concordant. The average SBP and DBP were highly concordant between both methods (r = 0.85 and 0.77), results somewhat superior to those reported by other researchers [25] . Both methods were equally effective in determining whether or not HTN was controlled. Nonconcordance was because of nocturnal HTN or abnormal BP patterns during sleep time in two-thirds of patients. This additional information provided by ABPM also explains why modification of treatment was significantly more frequent after ABPM than following HBPM.
Pickering et al. [21] proposed an algorithm that combines both ambulatory methods to diagnose HTN in previously untreated patients. Implementation of this algorithm in treated HTN patients is a novel approach that could improve diagnostic and therapeutic ability with lower cost and greater convenience. If this algorithm were applied to the patients studied, ABPM would only be required in 77 patients (35%) (with BP between 125/75 mmHg and 135/85 mmHg with HBPM) rather than in 200 patients. Although some patients with BP above 135/85 mmHg after HBPM could eventually require ABPM to confirm adequate degree of HTN control, it is clear that applying this algorithm can potentially reduce costs by taking advantage of both methods in a complementary manner. This algorithm could be applied to the majority of hypertensive patients; however, there are specific situations in which ABPM should be the first and the only outpatient method: BP variability evaluation over a short time period and mostly, in suspected cases of nocturnal HTN or in patients with sleep apnea, in which HBPM does not provide sufficient information.
Among the limitations of this study, it should be noted that with HBPM, BP measurements were not recorded during 7 days as recommended. However, the recent European guideline recommends that 3-day evaluation with a total of 12 samples is sufficient [1] . In the present study, readings were obtained during 4 days, with a total of 16 BP readings per patient; therefore, the information obtained was likely adequate. Treatment modification simply by finding an abnormal sleep BP behavior such as nondipper or over-dipper patterns in treated patients with normal BP is questionable. This issue is valid as both BP patterns have shown limited reproducibility, and modifying treatment by these daytime and night-time patterns has not resulted in cardiovascular event reduction [19] . However, in clinical practice, it is common to make therapeutic changes when these patterns are found in an ABPM report. If the presence of these patterns would not have promoted therapeutic changes in this study, treatment changes between ABPM and HBPM would have decreased from 75 versus 49% (P = 0.001) to 61 versus 49%, (P = 0.02), respectively, but would remain significant. Finally, this study did not aim to validate Pickering's algorithm, but rather to assess how it would have impacted patient care had it been applied. We believe that a formal prospective trial would be required to properly validate this algorithm.
Conclusion
In hypertensive patients, HBPM and ABPM show similar results on average SBP and DBP measurement, resulting in concordance to determine whether BP is appropriately controlled. Changes in BP medication were greater after ABPM because of its capability to detect nocturnal HTN and abnormal BP behavior during sleeping hours.
Application of an algorithm to use both types of BP monitoring in a complementary manner is reasonable and could potentially reduce costs.
